Different ALK inhibitors Lead to Different Outcomes in ALK-Positive Non-Small Cell Lung Cancer
source: pixabay.com

Different ALK inhibitors Lead to Different Outcomes in ALK-Positive Non-Small Cell Lung Cancer

Dr. Joshua Sabari, a professor at New York University's Department of Medicine, has recently spoken about the different treatment options for ALK-positive non-small cell lung cancer (NSCLC). Specifically, he discussed…

Continue Reading Different ALK inhibitors Lead to Different Outcomes in ALK-Positive Non-Small Cell Lung Cancer
Study of Non-Clear Cell Renal Cell Carcinoma Finds Strong Link to Proliferative Disease
source: pixabay.com

Study of Non-Clear Cell Renal Cell Carcinoma Finds Strong Link to Proliferative Disease

Non-clear cell renal cell carcinoma (nccRCC) has recently been found to have a very strong connection with various subtypes of proliferative disease. Further, this condition was found to have a…

Continue Reading Study of Non-Clear Cell Renal Cell Carcinoma Finds Strong Link to Proliferative Disease

 A Clinical Trial Confirms That Nivolumab Plus Chemotherapy Outperforms Immunotherapy Alone In Gastric Cancer Treatment

Healio recently published results of the CheckMate 649 study confirming the benefits of combining nivolumab and chemotherapy in treating newly diagnosed patients with gastroesophageal junction cancer and advanced gastric and…

Continue Reading  A Clinical Trial Confirms That Nivolumab Plus Chemotherapy Outperforms Immunotherapy Alone In Gastric Cancer Treatment
Research in Treatment Options for Primary Biliary Cholangitis (PBC)
Happy mature woman looking at friend in forest. Female friends are sitting at lakeshore. They are communicating in woodland.

Research in Treatment Options for Primary Biliary Cholangitis (PBC)

Acknowledgment: This story is sponsored by CymaBay Therapeutics and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant, vetted and valuable information…

Continue Reading Research in Treatment Options for Primary Biliary Cholangitis (PBC)